In contrast, a low anti-tumor effect of Pim and Gan was observed in PDCS that were generated from advanced pCRC with a low (<40% positive tumor cells) Hsp90α/β protein expression (patient IDs 5926 and 5941). This evidence concerns the gene HSP90AA1 and neoplasm.